195 related articles for article (PubMed ID: 37783759)
1. Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
Li N; van den Bergh JP; Boonen A; Wyers CE; Bours SPG; Hiligsmann M
Osteoporos Int; 2024 Feb; 35(2):293-307. PubMed ID: 37783759
[TBL] [Abstract][Full Text] [Related]
2. A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.
Beaupre LA; Lier D; Smith C; Evens L; Hanson HM; Juby AG; Kivi P; Majumdar SR;
Arch Osteoporos; 2020 Jul; 15(1):113. PubMed ID: 32699946
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
[TBL] [Abstract][Full Text] [Related]
4. A model-based cost-effectiveness analysis of fracture liaison services in China.
Li N; Si L; Boonen A; van den Bergh JP; Hiligsmann M
Arch Osteoporos; 2022 Oct; 17(1):132. PubMed ID: 36195760
[TBL] [Abstract][Full Text] [Related]
5. The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system.
Solomon DH; Patrick AR; Schousboe J; Losina E
J Bone Miner Res; 2014 Jul; 29(7):1667-74. PubMed ID: 24443384
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services.
Maas L; Boonen A; Li N; Wyers CE; Van den Bergh JP; Hiligsmann M
Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; ():1-10. PubMed ID: 38860294
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Osteoporosis Interventions to Improve Quality of Care After Upper Extremity Fracture: Results From a Randomized Trial (C-STOP Trial).
Majumdar SR; Lier DA; McAlister FA; Johnson JA; Rowe BH; Beaupre LA
J Bone Miner Res; 2019 Jul; 34(7):1220-1228. PubMed ID: 30779861
[TBL] [Abstract][Full Text] [Related]
9. Patient Healthcare Trajectory and its Impact on the Cost-Effectiveness of Fracture Liaison Services.
Senay A; Fernandes JC; Delisle J; Morin SN; Dragomir A; Nazha S; Perreault S
J Bone Miner Res; 2021 Mar; 36(3):459-468. PubMed ID: 33484586
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
Moriwaki K; Noto S
Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
[TBL] [Abstract][Full Text] [Related]
11. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.
Ito K
JAMA Netw Open; 2020 Dec; 3(12):e2027584. PubMed ID: 33258906
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Fracture Liaison Services Compared with Standard of Care in the Secondary Prevention of Fragility Fractures in Spain.
Naranjo A; Prieto-Alhambra D; Sánchez-Martín J; Pérez-Mitru A; Brosa M
Clinicoecon Outcomes Res; 2022; 14():249-264. PubMed ID: 35492806
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
Moriwaki K; Fukuda H
Osteoporos Int; 2019 Feb; 30(2):299-310. PubMed ID: 30610244
[TBL] [Abstract][Full Text] [Related]
15. Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
Wu CH; Kao IJ; Hung WC; Lin SC; Liu HC; Hsieh MH; Bagga S; Achra M; Cheng TT; Yang RS
Osteoporos Int; 2018 Jun; 29(6):1227-1242. PubMed ID: 29460102
[TBL] [Abstract][Full Text] [Related]
16. Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service.
Yates CJ; Chauchard MA; Liew D; Bucknill A; Wark JD
J Clin Densitom; 2015; 18(2):150-6. PubMed ID: 25797867
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of CT-Based Finite Element Modeling for Osteoporosis Screening in Secondary Fracture Prevention: An Early Health Technology Assessment in the Netherlands.
Li J; Viceconti M; Li X; Bhattacharya P; Naimark DMJ; Osseyran A
MDM Policy Pract; 2023; 8(2):23814683231202993. PubMed ID: 37900721
[TBL] [Abstract][Full Text] [Related]
18. The Potential Economic Benefits of an Alarm Service in Order Communication Systems in Korea: a Cost-Effectiveness Analysis of Less-Intensive Fracture Liaison Services Based on a Prospective Cohort Study.
Jang S; Lee YK; Ha YC; Jang S
Calcif Tissue Int; 2022 Oct; 111(4):380-390. PubMed ID: 35790553
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study.
Cooper MS; Palmer AJ; Seibel MJ
Osteoporos Int; 2012 Jan; 23(1):97-107. PubMed ID: 21953475
[TBL] [Abstract][Full Text] [Related]
20. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
